85 results
Page 2 of 5
424B3
at4medjv2gnk30j0u
9 Mar 22
Prospectus supplement
9:26am
424B3
sufz8prs
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
wwge qqe3nkjsz
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
424B3
19dc3ev574r5r
28 Feb 22
Prospectus supplement
12:02pm
424B3
e5aky0zy3oq82t8f8y
28 Feb 22
Prospectus supplement
12:01pm
6-K
EX-99.1
zf0fr4blskx20 0z3mgm
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
EX-99.1
017o9qq
25 Feb 22
Current report (foreign)
4:05pm
424B3
ykxub
22 Nov 21
Prospectus supplement
7:39am
424B3
nyzgwgo4eqcq8zzdeik5
22 Nov 21
Prospectus supplement
7:38am
6-K
EX-99.3
9bmop8f l1h5e2smm83
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
6-K
EX-99.1
4hrvdrpt2ys38f99wx5
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
6-K
EX-99.2
fy6cv82fzkwkfvs
13 Sep 21
Current report (foreign)
8:48am
424B3
mwvamnpt
23 Aug 21
Prospectus supplement
8:18am
424B3
lor3 v8a5vb22
23 Aug 21
Prospectus supplement
8:17am
6-K
EX-99.1
opt3 oa8kcoexv
23 Aug 21
Options Granted to Non-Executive Directors
8:16am
S-8
2hax8m pqxnr
6 Aug 21
Registration of securities for employees
2:49pm
424B3
bwewc4d sb06y
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
3x1uj4k mz5e40n
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
F-4
p8lp8yo
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
v9hqq
2 Jun 21
Prospectus supplement
10:10am